Cargando…
Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
The treatment of locally advanced rectal cancer (LARC) requires a multimodal approach combining neoadjuvant radiotherapy or chemoradiotherapy (CRT) and surgery. Predicting tumor response to CRT can guide clinical decision making and improve patient care while avoiding unnecessary toxicity and morbid...
Autores principales: | Machado Carvalho, Joao Victor, Dutoit, Valérie, Corrò, Claudia, Koessler, Thibaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913546/ https://www.ncbi.nlm.nih.gov/pubmed/36766755 http://dx.doi.org/10.3390/cells12030413 |
Ejemplares similares
-
Emerging Trends for Radio-Immunotherapy in Rectal Cancer
por: Corrò, Claudia, et al.
Publicado: (2021) -
Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
por: Sclafani, Francesco, et al.
Publicado: (2021) -
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016) -
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018) -
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer
por: Corrò, Claudia, et al.
Publicado: (2022)